Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct:218:279-287.
doi: 10.1016/j.ajo.2020.06.019. Epub 2020 Jul 2.

Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors

Affiliations

Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors

Deepika N Shah et al. Am J Ophthalmol. 2020 Oct.

Abstract

Purpose: This study evaluated the risk and risk factors for exudative retinal detachment (ERD) in ocular inflammatory diseases.

Design: Retrospective cohort study.

Methods: Patients with noninfectious ocular inflammation had been followed longitudinally between 1978 and 2007 at 4 US subspecialty uveitis centers. The main outcome measurements were occurrences of ERD and predictive factors.

Results: A total of 176 of 14,612 eyes with ocular inflammation presented with ERD. Among uveitis cases, Vogt-Koyanagi-Harada syndrome (VKH) (odds ratio [OR] = 109), undifferentiated choroiditis (OR = 9.18), sympathetic ophthalmia (OR = 8.43), primary or secondary panuveitis (OR = 7.09), multifocal choroiditis with panuveitis (OR = 4.51), and "other" forms of posterior uveitis (OR = 16.9) were associated with a higher prevalence of ERD. Among the 9,209 uveitic or scleritic eyes initially free of ERD and followed, 137 incident ERD cases were observed over 28,949 eye-years at risk (incidence rate = 0.47% [0.40%-0.56%/eye-year]). VKH (HR = 13.2), sympathetic ophthalmia (HR = 5.82), undifferentiated choroiditis (HR = 6.03), primary or secondary panuveitis (HR = 4.21), and rheumatoid arthritis (HR = 3.30) were significantly associated with incident ERD. A significant dose-response relationship with the prevalence and incidence of ERD were observed for AC cells and vitreous cell activity. African Americans had significantly higher prevalence and incidence of ERD.

Conclusions: Other ocular inflammatory conditions in addition to VKH syndrome and posterior scleritis were associated with increased risk of ERD, indicating that ERD does not necessarily dictate a diagnosis of VKH or posterior scleritis. In addition, the relationship between ERD and inflammatory severity factors implies that inflammation is a key predictive factor associated with developing ERD and requires early and vigorous control.

PubMed Disclaimer

Figures

Figures 1a and b:
Figures 1a and b:
Pie chart indicating the percentage of prevalent (present at initial visit; Figure 1a) and incident (Figure 1b) exudative retinal detachments associated with various inflammatory disease diagnoses.
Figure 2:
Figure 2:
Cumulative incidence of exudative retinal detachment (ERD)in patients with non-infectious uveitis and/or scleritis as a percentage over time; 95% confidence intervals are indicated in gray. 0.3 logMAR is equivalent to doubling of the visual angle.
Figure 3:
Figure 3:
Mean logMAR visual acuity in cases of non-infectious uveitis and/or scleritis are given at the visit preceding incident exudative retinal detachment, at the time exudative retinal detachment was diagnosed, and at the visit following exudative retinal detachment diagnosis.

References

    1. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990;14:303–8. 10.1007/BF00163549 - DOI - PubMed
    1. Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001;80:263–70. 10.1097/00005792-200107000-00005 - DOI - PubMed
    1. Rothova a, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra a. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332–6. 10.1136/bjo.80.4.332 - DOI - PMC - PubMed
    1. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluationof intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234–235. 10.1016/S0002-9394(14)74235-7 - DOI - PubMed
    1. Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol 2008;15:47–55. 10.1080/09286580701585892 - DOI - PubMed

Publication types

MeSH terms